Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

0.7499
+0.093914.31%
Post-market: 0.7310-0.0189-2.52%19:55 EDT
Volume:1.75M
Turnover:1.25M
Market Cap:60.07M
PE:1.99
High:0.7658
Open:0.6481
Low:0.6481
Close:0.6560
Loading ...
Mar 22, 2024

Major Issues Report

Form 8-K - Current report
Mar 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 25, 2023

Major Issues Report

Form 8-K - Current report
Aug 24, 2023

Correspondence

Form CORRESP - Correspondence
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 03, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2023

Major Issues Report

8-K - Current report